Category: News & Events

Cannara Biotech Shares to Begin Trading on the Frankfurt Exchange

MONTRÉAL, Feb. 11, 2019 /CNW/ – Cannara Biotech Inc. (“Cannara Biotech” or the “Company”) (CSE: LOVE) (FRA: 8CB), a vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced its common shares are listed for trading on the Frankfurt Stock Exchange under the trading symbol “8CB”. The Company’s common shares continue to be listed on the Canadian Securities Exchange under the trading symbol “LOVE”.  

Drone Delivery Canada to Unveil its 180kg (400lbs) Payload Cargo Delivery Drone ‘the Condor’ – February 19th at The Toronto Stock Exchange

TORONTO, Feb. 11, 2019 /PRNewswire/ – Drone Delivery Canada ‘DDC or the Company’ (TSX.V:FLT,OTC: TAKOF), is pleased to announce it will unveil DDC’s largest payload cargo delivery drone. With 180 kgs of capacity, ‘The Condor’ will be displayed at media, public and investor launch events at the TMX Broadcast Centre Gallery (located on the ground floor of 130 King St. West, Toronto, Ontario) on February 19, 2019.

Cannara Biotech Enters Cannabinoid-Infused Beverage Product Category

MONTRÉAL, Feb. 7, 2019 /CNW/ – Cannara Biotech Inc. (“Cannara Biotech” or the “Company”) (CSE: LOVE), a Montreal-based company that is building a vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced it has entered into a letter of intent with a leading Quebec microbrewery to develop cannabinoid-infused beverages. Following the regulations relating to edibles and beverages coming into effect next October, consumers will be able to purchase a variety of cannabinoid-infused beverages including non-alcoholic beer, kombucha and cider.

FSD Pharma Signs Collaboration and Profit-Sharing Agreement with Pharmastrip for Production and Delivery of Organic Medical Cannabis Infused in Oral Thin Film Strips

TORONTO, Feb. 7, 2019 /CNW/ – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company), a licensed producer under the Cannabis Act, announced today that it has completed a strategic investment of $1.5 million in Pharmastrip Corp. and signed a definitive collaboration and profit sharing agreement with the company, effective January 23, 2019. Under the terms of the agreement, FSD will install Pharmastrip proprietary equipment at its facility in Cobourg, Ontario. FSD will use the equipment to manufacture organic medical cannabis infused in oral thin film strips. Pharmastrip will grant FSD an exclusive, perpetual license to manufacture and sell the oral thin film strips in Canada.

FSD Pharma Announces Strategic Business Developments

TORONTO, Feb. 6, 2019 /CNW/ – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), announced that its Board of Directors has concluded a strategic assessment of the Company and has implemented changes in leadership and business practices to optimize operations. Accordingly, the Company announced today that Dr. Raza Bokhari, Executive Co-Chairman, has been appointed interim Chief Executive Officer of FSD Pharma, effective immediately. Dr. Bokhari’s appointment follows the termination of Rupert Haynes.

Enthusiast Gaming Hires US Sales Team and Opens San Francisco Office

TORONTO, Feb. 06, 2019 (GLOBE NEWSWIRE) — Enthusiast Gaming Holdings Inc. (TSXV: EGLX) (OTCQB: EGHIF), (“Enthusiast” or the “Company”), a gaming company building the world’s largest community of authentic gamers, is pleased to announce that it has opened a US-based office and hired a sales team to drive advertising sales and increase annual revenue. The US-based sales team is based in San Francisco and will be responsible for leading North American sales. This expands the company’s current reach with a sales team in San Francisco, London, UK, and the corporate head office in Toronto. The company kicked off the opening of the sales office with a West Coast advertising roadshow, meeting with top gaming publishers, global brands, and media agencies.

Gratomic Announces the Submission of Two Additional Exclusive Prospecting Licenses

February 5, 2019, TORONTO, ON – Gratomic Inc. (“Gratomic” or the “Company”)  (TSX-V: GRAT) (CB81–FRANKFURT) a vertically integrated graphite to graphenes, advanced materials development company announces the submission of two additional Exclusive Prospecting License (“EPL”) applications along the strike from its Aukam Graphite mine in Namibia. 

FSD Pharma Announces Signing of LOI with Solarvest to Develop and Test Pharma-Grade Cannabinoids out of Algae

TORONTO, Feb. 5, 2019 /CNW/ – FSD Pharma Inc. (CSE: HUGE) (OTC:  FSDDF) (“FSD Pharma”) and Solarvest BioEnergy Inc. (TSX-V: SVS) (“Solarvest”) (collectively, the “Parties”), a technology company which has developed an algal-based flexible production platform capable of producing health products, are pleased to announce that they have signed a non-binding letter of intent (“LOI”). The parties intend to enter into a definitive agreement (the “Collaborative Research Agreement”), under which Solarvest would conduct research using its algal expression technology to develop pharma-grade cannabinoids (the “Project Cannabinoids”), the Parties would make mutual investments into one another, and Solarvest would grant FSD Pharma an exclusive license over a subset of the Project Cannabinoids and certain royalty rights over all of the other Project Cannabinoids.